Luspatercept – REBLOZYL®
According to the NCI website, Luspatercept is a soluble, recombinant fusion protein. Check for active clinical trials using this agent. (NCI Thesaurus)
According to WIKI Luspatercept is a drug for the treatment of anemia in beta thalassemia and myelodysplastic syndromes.
Link to Drug Information Portal, a service of the U.S. National Library of Medicine, National Institutes of Health
Link to National Cancer Institute
Link to European Medicines Agency (EMEA)